Intranasal infection of Getah virus in experimental horses.
Abstract: Aerosol transmission in equine Getah virus (GV) infection was examined by intranasal inoculation with 10(3.0) to 10(7.0) TCID50 of the MI-110 strain in 7 experimental horses. The establishment of intranasal infection of GV was confirmed in all these horses by detecting serum neutralizing antibody against the MI-110 strain. Horses inoculated with more than 10(4.0) TCID50 of the virus manifested mild pyrexia, eruptions, serous nasal discharge, lymphopenia or monocytosis. Viremia ranging from 10(1.0) to 10(3.5) TCID50/0.2 ml occurred in horses inoculated with 10(5.0) TCID50, or more. Virus recovery from the nasal cavity was observed only in horses inoculated with 10(7.0) TCID50, and the viral titers recorded were 10(3.0) TICD50/ml or less. From these results, it is assumed that GV disseminated from the nasal cavity of naturally infected horses, except for intranasal infection with a lot of the virus, is probably very low in titer. So it seems to be rare that GV in natural cycles is spread from horse to horse by aerosol transmission.
Publication Date: 1991-10-01 PubMed ID: 1661175DOI: 10.1292/jvms.53.855Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research investigates how aerosol transmission of equine Getah virus works through an intranasal infection in horses, presenting evidence that suggests lower chances of virus spread between horses via this method.
Overview of Research
- The study investigated the action of equine Getah virus (GV) infection through aerosol transmission, focusing on intranasal inoculation, in horses. The GV is a mosquito-borne disease affecting horses.
- The researchers used the MI-110 strain of the GV and experimented with seven horses. The horses were subjected to different doses of the virus, ranging from 10(3.0) to 10(7.0) TCID50.
- The TCID50 (50% Tissue Culture Infective Dose) is a measure of the amount of virus that will produce pathological effects in 50% of cell cultures it infects.
Findings of the Study
- The results indicated that all horses developed an intranasal infection of GV, providing an indication of aerosol transmission. This was confirmed by detecting the serum-neutralizing antibody against the MI-110 strain in the horses.
- Upon inoculation with doses higher than 10(4.0) TCID50 of the virus, the horses demonstrated signs of the disease, such as mild pyrexia (fever), eruptions, serous nasal discharge, lymphopenia (abnormally low level of lymphocytes in the blood) or monocytosis (high count of monocytes in the blood).
Implications of the Findings
- Viremia (the presence of viruses in the blood) of varied levels was observed in horses treated with 10(5.0) TCID50 or higher doses. The researchers succeeded in retrieving the virus from the nasal cavity, but that was only the case for horses inoculated with the highest dose of 10(7.0) TCID50.
- These results suggest that the dissemination of GV from the nasal cavity of naturally infected horses, except for those with heavy intranasal infection, might be relatively ineffective.
- It appears that the potential for GV to spread between horses by aerosol transmission in a natural cycle may be small. This is because, based on the study, the virus concentration required for efficient transmission seems too high to be realistic in real-world scenarios.
Cite This Article
APA
Kamada M, Kumanomido T, Wada R, Fukunaga Y, Imagawa H, Sugiura T.
(1991).
Intranasal infection of Getah virus in experimental horses.
J Vet Med Sci, 53(5), 855-858.
https://doi.org/10.1292/jvms.53.855 Publication
Researcher Affiliations
- Epizootic Research Station, Equine Research Institute, Japan Racing Association, Tochigi.
MeSH Terms
- Aerosols
- Alphavirus / immunology
- Alphavirus / isolation & purification
- Alphavirus / physiology
- Animals
- Antibodies, Viral / blood
- Female
- Horse Diseases / transmission
- Horses
- Male
- Nasal Mucosa / microbiology
- Togaviridae Infections / transmission
- Togaviridae Infections / veterinary
- Viremia / microbiology
- Viremia / veterinary
Citations
This article has been cited 10 times.- Takeishi M, Kuwata R, Ono T, Sasaki A, Ogata M, Iwata E, Taji S, Koike M, Nemoto M, Bannai H, Isawa H, Maeda K, Morikawa S, Kitagawa H, Yoshikawa Y. Seroconversion of anti-Getah virus antibody among Japanese native Noma horses around 2012. J Vet Med Sci 2022 Nov 18;84(12):1605-1609.
- Li B, Wang H, Liang G. Getah Virus (Alphavirus): An Emerging, Spreading Zoonotic Virus. Pathogens 2022 Aug 20;11(8).
- Shi N, Qiu X, Cao X, Mai Z, Zhu X, Li N, Zhang H, Zhang J, Li Z, Shaya N, Lu H, Jin N. Molecular and serological surveillance of Getah virus in the Xinjiang Uygur Autonomous Region, China, 2017-2020. Virol Sin 2022 Apr;37(2):229-237.
- Björnström A, Blomström AL, Singh MC, Hesson JC. Sindbis virus neutralising antibodies detected in Swedish horses. One Health 2021 Jun;12:100242.
- Lu G, Ou J, Ji J, Ren Z, Hu X, Wang C, Li S. Emergence of Getah Virus Infection in Horse With Fever in China, 2018. Front Microbiol 2019;10:1416.
- Sam SS, Teoh BT, Chee CM, Mohamed-Romai-Noor NA, Abd-Jamil J, Loong SK, Khor CS, Tan KK, AbuBakar S. A quantitative reverse transcription-polymerase chain reaction for detection of Getah virus. Sci Rep 2018 Dec 5;8(1):17632.
- Brown CM, Timoney PJ. Getah virus infection of Indian horses. Trop Anim Health Prod 1998 Aug;30(4):241-52.
- Wu Y, Gao X, Kuang Z, Lin L, Zhang H, Yin L, Hong J, Ren B, Li Q, Wang L. Isolation and pathogenicity of a highly virulent group III porcine Getah virus in China. Front Cell Infect Microbiol 2024;14:1494654.
- Zhong D, Zheng J, Ma Z, Wang Y, Wei J. Rapid Detection of Getah Virus Antibodies in Horses Using a Recombinant E2 Protein-Based Immunochromatographic Strip. Animals (Basel) 2024 Aug 8;14(16).
- Mashin VV, Sergeev AN, Martynova NN, Sergeev AA, Lys'ko KA, Raikov AO, Kataeva VV, Zagidullin NV. Viral Safety Issues in the Production and Manufacturing of Human Immunoglobulin Preparations from Equine Plasma/Serum. Pharm Chem J 2022;56(4):532-537.
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists